Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-04-01 Sale |
2025-04-03 4:30 pm |
Blueprint Medicines Corp | BPMC | Haviland Kate CHIEF EXECUTIVE OFFICER |
2,498 | $86.65 | $216,461 | 165,929 (Direct) |
View |
| 2025-03-05 Sale |
2025-03-07 4:08 pm |
Blueprint Medicines Corp | BPMC | Haviland Kate CHIEF EXECUTIVE OFFICER |
16,151 | $88.8 | $1,434,209 | 168,427 (Direct) |
View |
| 2025-01-21 Sale |
2025-01-23 7:56 pm |
Blueprint Medicines Corp | BPMC | Haviland Kate CHIEF EXECUTIVE OFFICER |
1,446 | $110.24 | $159,407 | 149,378 (Direct) |
View |
| 2024-11-29 Sale |
2024-12-03 5:33 pm |
Blueprint Medicines Corp | BPMC | Haviland Kate CHIEF EXECUTIVE OFFICER |
2,353 | $96.6 | $227,304 | 150,824 (Direct) |
View |
| 2024-03-07 Sale |
2024-03-11 6:27 pm |
Blueprint Medicines Corp | BPMC | Haviland Kate CHIEF EXECUTIVE OFFICER |
12,464 | $90.69 | $1,130,360 | 153,177 (Direct) |
View |
| 2023-03-06 Sale |
2023-03-08 9:24 pm |
Blueprint Medicines Corp | BPMC | Haviland Kate CHIEF EXECUTIVE OFFICER |
6,640 | $45.69 | $303,354 | 125,641 (Direct) |
View |
| 2022-11-03 Purchase |
2022-11-07 4:07 pm |
Blueprint Medicines Corp | BPMC | Haviland Kate CHIEF EXECUTIVE OFFICER |
1,100 | $43.98 | $48,378 | 92,281 (Direct) |
View |
| 2022-03-03 Sale |
2022-03-08 4:05 pm |
Blueprint Medicines Corp | BPMC | Haviland Kate CHIEF OPERATING OFFICER |
2,767 | $58.72 | $162,481 | 91,181 (Direct) |
View |
| 2021-12-13 Sale |
2021-12-15 4:23 pm |
Blueprint Medicines Corp | BPMC | Haviland Kate Chief Operating Officer |
1,000 | $98.3 | $98,296 | 54,539 (Direct) |
View |
| 2021-09-13 Sale |
2021-09-15 4:13 pm |
Blueprint Medicines Corp | BPMC | Haviland Kate Chief Operating Officer |
1,000 | $99.94 | $99,936 | 55,539 (Direct) |
View |
| 2021-06-28 Sale |
2021-06-30 4:02 pm |
Blueprint Medicines Corp | BPMC | Haviland Kate Chief Operating Officer |
1,000 | $90.24 | $90,238 | 56,539 (Direct) |
View |
| 2021-03-15 Sale |
2021-03-17 5:48 pm |
Blueprint Medicines Corp | BPMC | Haviland Kate Chief Operating Officer |
1,000 | $105.6 | $105,603 | 57,539 (Direct) |
View |
| 2021-03-04 Sale |
2021-03-05 5:52 pm |
Blueprint Medicines Corp | BPMC | Haviland Kate Chief Operating Officer |
1,952 | $86.77 | $169,370 | 53,948 (Direct) |
View |
| 2020-11-16 Sale |
2020-11-18 4:23 pm |
Blueprint Medicines Corp | BPMC | Haviland Kate Chief Operating Officer |
409 | $100.27 | $41,010 | 47,429 (Direct) |
View |
| 2020-10-16 Sale |
2020-10-20 4:09 pm |
Blueprint Medicines Corp | BPMC | Haviland Kate Chief Operating Officer |
13,334 | $101.23 | $1,349,848 | 47,838 (Direct) |
View |
| 2020-09-22 Sale |
2020-09-24 4:19 pm |
Blueprint Medicines Corp | BPMC | Haviland Kate Chief Operating Officer |
3,143 | $85.49 | $268,695 | 42,840 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-01 Option Award |
2025-03-04 5:19 pm |
N/A 2035-02-28 |
Blueprint Medicines Corp | BPMC | Haviland Kate CHIEF EXECUTIVE OFFICER |
105,600 | $0 | 254,978 (Direct) |
View |
| 2024-09-12 Option Award |
2024-09-16 4:38 pm |
N/A 2034-09-12 |
Bicara Therapeutics Inc. | BCAX | Haviland Kate Director |
23,746 | $0 | 23,746 (Direct) |
View |
Ownership |
2024-09-12 9:00 pm |
N/A N/A |
Bicara Therapeutics Inc. | BCAX | Haviland Kate Director |
0 | $0 | 59,500 (Direct) |
View |
| 2024-06-17 Option Award |
2024-06-18 4:20 pm |
N/A 2034-06-16 |
Fulcrum Therapeutics Inc. | FULC | Haviland Kate Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2024-03-01 Option Award |
2024-03-06 4:18 pm |
N/A 2034-03-01 |
Blueprint Medicines Corp | BPMC | Haviland Kate CHIEF EXECUTIVE OFFICER |
120,000 | $0 | 245,641 (Direct) |
View |
| 2023-06-27 Option Award |
2023-06-29 4:16 pm |
N/A 2033-06-26 |
Fulcrum Therapeutics Inc. | FULC | Haviland Kate Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2023-03-01 Option Award |
2023-03-03 8:07 pm |
N/A 2033-03-01 |
Blueprint Medicines Corp | BPMC | Haviland Kate CHIEF EXECUTIVE OFFICER |
120,000 | $0 | 212,281 (Direct) |
View |
| 2022-06-27 Option Award |
2022-06-29 5:00 pm |
N/A 2032-06-26 |
Fulcrum Therapeutics Inc. | FULC | Haviland Kate Director |
19,000 | $0 | 19,000 (Direct) |
View |
| 2022-03-01 Option Award |
2022-03-03 8:07 pm |
N/A 2032-03-01 |
Blueprint Medicines Corp | BPMC | Haviland Kate CHIEF OPERATING OFFICER |
120,000 | $0 | 173,948 (Direct) |
View |
| 2021-12-13 Exercise |
2021-12-15 4:23 pm |
N/A N/A |
Blueprint Medicines Corp | BPMC | Haviland Kate Chief Operating Officer |
1,000 | $36.05 | 54,539 (Direct) |
View |
| 2021-12-13 Exercise |
2021-12-15 4:23 pm |
N/A 2027-02-16 |
Blueprint Medicines Corp | BPMC | Haviland Kate Chief Operating Officer |
1,000 | $0 | 54,539 (Direct) |
View |
| 2021-09-13 Exercise |
2021-09-15 4:13 pm |
N/A N/A |
Blueprint Medicines Corp | BPMC | Haviland Kate Chief Operating Officer |
1,000 | $36.05 | 55,539 (Direct) |
View |
| 2021-09-13 Exercise |
2021-09-15 4:13 pm |
N/A 2027-02-16 |
Blueprint Medicines Corp | BPMC | Haviland Kate Chief Operating Officer |
1,000 | $0 | 55,539 (Direct) |
View |
| 2021-06-28 Exercise |
2021-06-30 4:02 pm |
N/A N/A |
Blueprint Medicines Corp | BPMC | Haviland Kate Chief Operating Officer |
1,000 | $36.05 | 56,539 (Direct) |
View |
| 2021-06-28 Exercise |
2021-06-30 4:02 pm |
N/A 2027-02-16 |
Blueprint Medicines Corp | BPMC | Haviland Kate Chief Operating Officer |
1,000 | $0 | 56,539 (Direct) |
View |
| 2021-06-09 Option Award |
2021-06-11 5:10 pm |
N/A 2031-06-08 |
Fulcrum Therapeutics Inc. | FULC | Haviland Kate Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2021-03-15 Exercise |
2021-03-17 5:48 pm |
N/A N/A |
Blueprint Medicines Corp | BPMC | Haviland Kate Chief Operating Officer |
1,000 | $36.05 | 57,539 (Direct) |
View |
| 2021-03-15 Exercise |
2021-03-17 5:48 pm |
N/A 2027-02-16 |
Blueprint Medicines Corp | BPMC | Haviland Kate Chief Operating Officer |
1,000 | $0 | 57,539 (Direct) |
View |
| 2021-03-01 Option Award |
2021-03-03 4:30 pm |
N/A 2031-03-01 |
Blueprint Medicines Corp | BPMC | Haviland Kate Chief Operating Officer |
39,187 | $0 | 82,025 (Direct) |
View |
| 2020-11-16 Exercise |
2020-11-18 4:23 pm |
N/A N/A |
Blueprint Medicines Corp | BPMC | Haviland Kate Chief Operating Officer |
409 | $36.05 | 47,429 (Direct) |
View |
| 2020-11-16 Exercise |
2020-11-18 4:23 pm |
N/A 2027-02-16 |
Blueprint Medicines Corp | BPMC | Haviland Kate Chief Operating Officer |
409 | $0 | 47,429 (Direct) |
View |
| 2020-10-16 Exercise |
2020-10-20 4:09 pm |
N/A N/A |
Blueprint Medicines Corp | BPMC | Haviland Kate Chief Operating Officer |
13,334 | $36.05 | 47,838 (Direct) |
View |
| 2020-10-16 Exercise |
2020-10-20 4:09 pm |
N/A 2027-02-16 |
Blueprint Medicines Corp | BPMC | Haviland Kate Chief Operating Officer |
13,334 | $0 | 47,838 (Direct) |
View |
| 2020-09-22 Exercise |
2020-09-24 4:19 pm |
N/A N/A |
Blueprint Medicines Corp | BPMC | Haviland Kate Chief Operating Officer |
3,143 | $16.28 | 42,840 (Direct) |
View |
| 2020-09-22 Exercise |
2020-09-24 4:19 pm |
N/A 2026-02-01 |
Blueprint Medicines Corp | BPMC | Haviland Kate Chief Operating Officer |
3,143 | $0 | 42,840 (Direct) |
View |
| 2020-06-11 Option Award |
2020-06-15 4:15 pm |
N/A 2030-06-10 |
Fulcrum Therapeutics Inc. | FULC | Haviland Kate Director |
9,285 | $0 | 9,285 (Direct) |
View |